<DOC>
	<DOCNO>NCT02255851</DOCNO>
	<brief_summary>The SENTINEL Post-Market Registry prospective , multi-center , registry use CE-Marked Sentinel System subject severe symptomatic calcify native aortic valve stenosis indicate TAVR . Subjects enrol registry undergo TAVR + Sentinel . Basic demographic information detailed procedural data capture documented registry case report form . All Sentinel filter send histopathology independent core-lab .</brief_summary>
	<brief_title>Sentinel ( TM ) Post-Market Registry</brief_title>
	<detailed_description />
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>1 . Approved indication commercially available CEMarked TAVR device . 2 . Compatible left common carotid artery ( 6.5 10 mm ) brachiocephalic artery ( 9 15 mm ) diameter without significant stenosis ( &gt; 70 % ) . 3 . The subject subject 's legal representative inform nature registry , agree provision provide write informed consent approve Ethics Committee respective site . 1 . Vasculature right extremity preclude 6Fr sheath radial/brachial access 2 . Inadequate circulation right extremity evidence sign artery occlusion absence radial brachial pulse 3 . Hemodialysis shunt , graft , arteriovenous fistula involve upper extremity vasculature 4 . Patients antiplatelet and/or anticoagulant therapy contraindicate , refuse transfusion 5 . Excessive tortuosity right radial/brachial/subclavian artery prevent Sentinel device access insertion 6 . Patient whose brachiocephalic leave carotid artery reveals significant stenosis , ectasia , dissection , aneurysm ostium within 3 cm ostium 7 . Currently participate investigational drug investigational ( non CEmark ) device study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>select TAVR heart team consensus</keyword>
	<keyword>treat CE-Marked TAVR device</keyword>
</DOC>